Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Institute of Medicine, Food and Nutrition Board, Board on Health Sciences Policy, Board on Health Care Services, Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, John R. Ball, Christine M. Micheel
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Anno:
2010
Edizione:
1
Casa editrice:
National Academies Press
Lingua:
english
Pagine:
334
ISBN 10:
0309151309
ISBN 13:
9780309151306
File:
PDF, 2.60 MB
IPFS:
,
english, 2010
Amazon 
Barnes & Noble 
Bookshop.org 
Converti i file
Più risultati di ricerca
Altri vantaggi 
